key: cord-0741461-iz9klwvp
authors: Siqueira, Andrei Santos; Lima, Alex Ranieri Jerônimo; de Souza, Rafael Conceição; Santos, Alberdan Silva; Vianez Júnior, João Lídio da Silva Gonçalves; Gonçalves, Evonnildo Costa
title: In silico analysis of the cyanobacterial lectin scytovirin: new insights into binding properties
date: 2017-07-29
journal: Mol Biol Rep
DOI: 10.1007/s11033-017-4116-1
sha: b9f90c37d0dca4e2f389333472a5dff18a39f64f
doc_id: 741461
cord_uid: iz9klwvp

Scytovirin is a lectin isolated from the cyanobacterium Scytonema varium that has shown activity against HIV, SARS coronavirus and Zaire Ebola virus. Its 95 amino acids are divided into two structural domains (SD), the first spanning amino acids 1–48 (SD1) and the second 49–95 (SD2). Interestingly, the domains are nearly identical but differ in their affinities for carbohydrates. With the aim of enhancing understanding of the binding properties of scytovirin, we performed molecular dynamics (MD) simulations of scytovirin complexed with Man4. We set up three systems: (i) Man4 bound to both domains (SD1 + SD2) using the full-length protein; (ii) Man4 bound to an incomplete protein, containing only SD1 and (iii) Man4 bound to an incomplete protein containing only SD2. Contrary to other reports, binding free energy results suggest that Man4 can bind simultaneously to SD1 and SD2 binding regions, but SD1 individually has the best values of energy and the best affinity for Man4. Decomposition of the binding free energy showed that the residues that interact with Man4 were different in the three systems, suggesting that the binding mechanism of Man4 varies between full-length protein, SD1 and SD2. The results presented here may help to formulate strategies to use scytovirin and promote mutagenesis studies to improve the antiviral activity of scytovirin.

The phylum cyanobacteria has been explored for a long time due to its high biotechnological potential, mainly because of bioactive compound production [1, 2] . In this regard, some lectins produced by algae and cyanobacteria are notable for their high antiviral activity against HIV, severe acute respiratory syndrome (SARS) coronavirus and Zaire Ebola virus [3] . In general, those proteins act by preventing the fusion of the virus with the host cell through binding to viral glycoproteins.

Among the lectins isolated from cyanobacteria, cyanovirin, one of the most well-known; it is produced by the species Nostoc ellipsosporum and presents 101 amino acids and a molecular weight of 10 kDa. Recombinant cyanovirin expressed in soybean seeds is shown to be biologically active in anti-HIV assays [4] . The cyanobacterial lectin microvirin, originally isolated from Microcystis aeruginosa PCC 7806, which shares 33% similarity with the cyanovirin, is unusual in that it potently inhibits HIV-1 with negligible toxicity compared to cyanovirin [3, 5] . A third cyanobacterial lectin with broad biotechnological potential given its biological activity is scytovirin, a lectin that was isolated from the cyanobacterium Scytonema varium [6] . Cyanobacterial lectin scytovirin has 95 amino acids with a molecular mass of approximately 9.7 kDa divided into two structural domains (SD), the first spanning amino acids 1-48 (SD1) and the second 49-95 (SD2). These are nearly Abstract Scytovirin is a lectin isolated from the cyanobacterium Scytonema varium that has shown activity against HIV, SARS coronavirus and Zaire Ebola virus. Its 95 amino acids are divided into two structural domains (SD), the first spanning amino acids 1-48 (SD1) and the second 49-95 (SD2). Interestingly, the domains are nearly identical but differ in their affinities for carbohydrates. With the aim of enhancing understanding of the binding properties of scytovirin, we performed molecular dynamics (MD) simulations of scytovirin complexed with Man4. We set up three systems: (i) Man4 bound to both domains (SD1 + SD2) using the full-length protein; (ii) Man4 bound to an incomplete protein, containing only SD1 and (iii) Man4 bound to an incomplete protein containing only SD2. Contrary to other reports, binding free energy results suggest that Man4 can bind simultaneously to SD1 and SD2 binding regions, but SD1 individually has the best values of energy and the best affinity for Man4. Decomposition of the binding free energy showed that the residues that interact with Man4 were different in the three systems, suggesting that the binding mechanism of Man4 varies between full-length protein, SD1 and SD2. The results presented here may help to formulate strategies to use scytovirin and identical, although they present different affinities and may bind independently to ligand carbohydrates [7] . Since scytovirin can bind to HIV glycoproteins gp160, gp120 and gp41 and to the Zaire Ebola virus mucin domain and shows antiviral activity against these viruses [8, 9] , it is currently being investigated as a potential antiviral microbicide candidate.

These lectins are not HIV-specific because their target high-mannose arrays are present in all HIV subtype envelope glycoproteins and in other viruses. Because such a mannose content is uncommon in mammalian cells, these compounds are not likely to be toxic to human cells in vivo [10, 11] . However, it has been demonstrated that HIV can develop resistance to HIV by deglycosylation in site-specific residues, although multiple mutations are necessary to make this happen [12] . Therefore, it is very important to know all the structural aspects of the interaction of scytovirin with the high-mannose arrays in order to develop an effective microbicide.

Adams et al. [13] developed a study with microarray carbohydrates and determined that the minimal core structures necessary for scytovirin binding are the D3 arm of Man9, Manα(1-2) Manα(1-2) Manα(1-6)Man, also known as Man4. A binding analysis of Man4 with scytovirin by titration concluded that SD1 and SD2 act independently and not cooperatively [14] . Since some aspects of this relationship remained unclear, in our study we performed molecular dynamics (MD) simulations of scytovirin complexed with Man4 in order to better understand its binding properties.

There are three scytovirin structures in protein data bank (PDB). For our study we chose a structure resolved by high resolution X-ray diffraction, which was 1.00 Å (PDB code: 2QSK) [15] . Its disulfide-bonding pattern differs from that described in previously published mass spectrometry and NMR studies [8] .

The structure of Man4 was constructed according to Adams et al. [13] from the Glycam website (http://www. glycam.org/). Gaussian09 was employed to optimize and calculate the RESP charges of the structure. To determine an initial conformation for Man4, we performed a docking simulation with Molegro Virtual Docking 5 software. Mol-Dock scoring function with a grid resolution of 0.30 was used to rank the solutions, toggling on Internal ES, Internal HBond and Sp2-Sp2 torsions. The radius of the search area covered all key residues described as ligation sites [8] . Docking results were further refined by energy minimization and Hbonds to optimize hydrogen bonds after docking. Each docking had 10 runs, population size of 100 and max iterations of 2000. Three dockings were performed, one of them based on full-length scytovirin and the two others based on SD1 and SD2, individually.

To determine the protonation state of the residues, we used the PDB2PQR server (http://nbcr-222.ucsd.edu/pdb-2pqr_2.0.0/) considering a pH of 7.0. AMBER 12 package was used to perform all steps of preparation and MD [16] . Carbohydrate parameters were obtained from the GLY-CAM06 [17] force field. For the protein and ions, FF99SB [18] and GAFF [19] force fields were used, respectively. Next, we set up three systems: (i) Man4 bound to both domains (SD1 + SD2) using the full-length protein; (ii) Man4 bound to an incomplete protein, containing only SD1, (iii) Man4 bound to an incomplete protein containing only SD2. The three systems were constructed, each one with a ligand (Man4), Cl − ions to neutralize the charges and the TIP3P water molecules in a cubic box with 12 Å in each direction of the protein. Sander software, which is included in AMBER 12, performed the energy minimization in five stages. The first four stages used 3000 cycles of steepest descent and 5000 cycles of conjugate gradients. In the remaining stage, 5000 cycles of steepest descent and 30,000 cycles of conjugate gradients were used. The heavy atoms had their movement restrained by a harmonic potential of 1000 Kcal/mol Å 2 , while in the final step all atoms were free. For heating and equilibration, 14 steps were used. A harmonic potential of 25 Kcal/mol Å 2 was employed to restrain the heavy atoms in the initial stages. In the step 13, the restraining force was set to 0. The temperature was gradually increased, until it reached 300 K. Langevin dynamics (thermostat) were employed with a collision frequency of 3.0 ps −1 . This method is significantly more efficient at equilibrating the system temperature than the Berendsen temperature coupling scheme that was recommended for older versions of AMBER [16] . The heating procedure lasted 650 ps until step 13 and was performed using an NVT ensemble. Afterwards, a 2 ns equilibration phase was employed in an NPT ensemble. The SHAKE algorithm was employed to restrict the vibration of the ligations of all hydrogen atoms. The Particle Mesh Ewald method was used for calculating electrostatic interactions using a cutoff value of 10.0 Å. Thus, 210 ns MD was produced in an NVT ensemble, for each system. The cpptraj module was used to compute the root mean square deviation (RMSD) of both trajectories, considering the heavy atoms of the main chain. 5000 snapshots from the last 10 ns of the MD simulations were used to calculate the free energies using MM-GBSA, MM-PBSA and SIE methods [20] [21] [22] .

The best poses obtained in molecular docking are shown in Table 1 . According to these results, the best MolDock score was obtained when Man4 binds simultaneously to SD1 and SD2, interacting with residues of both domains (Table 1) . SD2 shows a higher number of residues interacting with Man4. The aromatic residues described as important to scytovirin function [14] are present in the three docking analyses performed here. These three conformations were used as an input to build the MD systems.

We generated production runs of 210 ns for full-length scytovirin (SD1 + SD2), SD1 and SD2 complexed individually with Man4. The behavior of the protein and the ligand was different in each analysis. The most stable system was the full-length scytovirin complexed with Man4, which shows RMSD values around 1 Å for protein and 3 Å for Man4 (Fig. 1) . The system based on SD1 and Man4 complex presented a higher number of conformation changes in comparison to the other systems, but the SD1 became more stable at the end of the simulation. Nonetheless, Man4 remained complexed with the protein during all MD simulations. It was also observed that during the entire simulation with the full-length scytovirin, Man4 maintained interactions with residues of SD1 and SD2 simultaneously (Fig. 2) .

The results of MM-GBSA, MM-PBSA and SIE methods are presented in Table 2 . These results corroborate the experimental approach in which SD1 individually has higher affinity for Man4 than full-length scytovirin and SD2 [7] . In the three methods used here, the SD1 showed the best values of binding free energy. When the energy decomposition was performed, it was possible to observe that different residues are involved with Man4 binding. Additionally, scytovirin presented several residues contributing along full-length protein (Fig. 3) , including the regions with aromatic residues like Trp8 and Phe47. We can observe that the most important residues of SD1 binding (Glu10, Ans18 and Arg30) are conserved in SD2 as Glu58, Ans66 and Arg78, but they do not contribute to interaction when SD2 is complexed individually with Man4 ( Fig. 3; Table 2 ).

This study is the first theoretical analysis to use the disulfide bonds pattern proposed by Moulaei et al. [15] , which is Cys20-Cys32 and Cys26-Cys38 in SD1, Cys68-Cys80 and Cys74-Cys86 in SD2 and, Cys7-Cys55 in the interdomain region. It is noteworthy that, based on previous reports providing contradictory results for the disulfide pairing in each individual domain, the pattern used here was proven by Moulaei et al. [23] , who used N-terminal sequencing and mass spectrometry to analyze proteolytic fragments of native scytovirin obtained at an acidic pH.

Our results (Fig. 3) corroborate the McFeeters et al. [14] study wherein the key residues which interact with Man4 are essentially Cys7, Trp8, Asn9, Glu10, Arg43, Asp46, Phe47, Cys55, Asp57, Glu58, Lys60, Asp75. On the other hand, these authors propose that the two carbohydrate binding sites (one in each domain) of scytovirin function independently with no cooperativity, although, our results (Figs. 2, 3) reveal that Man4 can bind simultaneously to residues of SD1 and SD2. However, SD1 individually has the best values for binding free energy and higher affinity (Table 2 ). This also corroborates Xiong et al. [7] , who demonstrated that scytovirin has two domains with different affinity for carbohydrates.

In this sense, we propose a way to try to explain the difference of affinity between the two nearly identical domains-since SD1 has three uncharged asparagineswhere two of them are substituted by charged residues in SD2. This occurs in such a way that in SD2, charged residues Asp57 and Lys 60, replace asparagine residues and create an electrostatic force capable of separating Man4 from the key residues Ans66 and Arg78, which are Ans18 and Arg30 in SD1, respectively (Fig. 3) . This event affects the formation of interactions in the same pattern as observed in SD1 and that affect the binding free energy of SD2. Finally, the use of lectins in the treatment and prevention of viral diseases is a very promising application [3, 5] , and it is thus important to know how theseproteins act to prevent microbial infection. In the case of scytovirin, the mechanism for binding to Man4 varies between full-length protein, SD1 and SD2. Overall, the results presented here may help to formulate strategies for using scytovirin as a potential antiviral drug as well for promoting mutagenesis studies that can improve the affinity of scytovirin for the ligand carbohydrates. 

Cyanobacteria-a potential source of new biologically active substances

Pharmaceutical applications of cyanobacteria-a review

Algal lectins as potential HIV microbicide candidates

Engineering soya bean seeds as a scalable platform to produce cyanovirin-N, a non-ARV microbicide against HIV

Structural studies of algal lectins with anti-HIV activity

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium

Potent anti-HIV activity of scytovirin domain 1 peptide

The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors

The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin

Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV

Microbicide drug candidates to prevent HIV infection

Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions

Scytovirin engineering improves carbohydrate affinity and HIV-1 entry inhibition

Atomic-resolution crystal structure of the antiviral lectin scytovirin

GLYCAM06: a generalizable biomolecular force field. Carbohydrates

Evaluating the performance of the ff99SB force field based on NMR scalar coupling data

Development and testing of a general amber force field

Assessing the performance of the MM/PBSA and MM/GBSA methods: 1. The accuracy of binding free energy calculations based on molecular dynamics simulations

Archontis (2012) MM-GB(PB)SA calculations of protein-ligand binding free energies

Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 2. Benchmark in the CSAR-2010 scoring exercise

Topology of the disulfide bonds in the antiviral lectin scytovirin

Acknowledgements We acknowledge Fundação Amazônia de Amparo a Estudos e Pesquisas do Pará (FAPESPA) for financially supporting (ICAAF 099/2014) our project. Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) also supported individual authors through Grant 311686/2015-0 (ECG).